Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04120818Completed

Inflammatory Cytokines in Congenital Cataract After Lensectomy and Anterior Vitrectomy

Role: lead

NCT04077489Not ApplicableCompleted

Effects of 23-gauge Lensecotomy Combined With Anterior Vitrectomy on Macular in Children With Congenital Cataract

Role: lead

NCT01305005Completed

Effect of Phacoemulsification on Ocular Blood Flow in Human

Role: lead

NCT03905044Completed

Clinical Characteristics in Congenital Cataract Eyes

Role: lead

NCT03558126Not ApplicableCompleted

Silicone Tube for the Surgical Treatment of Glaucoma

Role: lead

NCT03142269Not ApplicableCompleted

The Influences Of Anterior Capsule Polishing On Anterior Capsular Changes and Intraocular Lenses Stability of Super High Myopic Eyes

Role: lead

All 6 trials loaded